Menu
GWAS Study

Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis.

van Es MA, Veldink JH, Saris CG et al.

19734901 PubMed ID
GWAS Study Type
19808 Participants
37 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

VE
van Es MA
VJ
Veldink JH
SC
Saris CG
BH
Blauw HM
VV
van Vught PW
BA
Birve A
LR
Lemmens R
SH
Schelhaas HJ
GE
Groen EJ
HM
Huisman MH
VD
van der Kooi AJ
DV
de Visser M
DC
Dahlberg C
EK
Estrada K
RF
Rivadeneira F
HA
Hofman A
ZM
Zwarts MJ
VD
van Doormaal PT
RD
Rujescu D
SE
Strengman E
GI
Giegling I
MP
Muglia P
TB
Tomik B
SA
Slowik A
UA
Uitterlinden AG
HC
Hendrich C
WS
Waibel S
MT
Meyer T
LA
Ludolph AC
GJ
Glass JD
PS
Purcell S
CS
Cichon S
NM
Nöthen MM
WH
Wichmann HE
SS
Schreiber S
VS
Vermeulen SH
KL
Kiemeney LA
WJ
Wokke JH
CS
Cronin S
MR
McLaughlin RL
HO
Hardiman O
FK
Fumoto K
PR
Pasterkamp RJ
MV
Meininger V
MJ
Melki J
LP
Leigh PN
SC
Shaw CE
LJ
Landers JE
AA
Al-Chalabi A
BR
Brown RH
RW
Robberecht W
AP
Andersen PM
OR
Ophoff RA
VD
van den Berg LH
Chapter II

Abstract

Summary of the research findings

We conducted a genome-wide association study among 2,323 individuals with sporadic amyotrophic lateral sclerosis (ALS) and 9,013 control subjects and evaluated all SNPs with P < 1.0 x 10(-4) in a second, independent cohort of 2,532 affected individuals and 5,940 controls. Analysis of the genome-wide data revealed genome-wide significance for one SNP, rs12608932, with P = 1.30 x 10(-9). This SNP showed robust replication in the second cohort (P = 1.86 x 10(-6)), and a combined analysis over the two stages yielded P = 2.53 x 10(-14). The rs12608932 SNP is located at 19p13.3 and maps to a haplotype block within the boundaries of UNC13A, which regulates the release of neurotransmitters such as glutamate at neuromuscular synapses. Follow-up of additional SNPs showed genome-wide significance for two further SNPs (rs2814707, with P = 7.45 x 10(-9), and rs3849942, with P = 1.01 x 10(-8)) in the combined analysis of both stages. These SNPs are located at chromosome 9p21.2, in a linkage region for familial ALS with frontotemporal dementia found previously in several large pedigrees.

2,323 European ancestry cases, 9,013 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

19808
Total Participants
GWAS
Study Type
Yes
Replicated
2,532 European ancestry cases, 5,940 European ancestry controls
Replication Participants
European
Ancestry
Sweden, U.S., Netherlands, Belgium, Poland, Germany, U.K., France
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.